Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells

Abstract

Loss of the tumor suppressor gene NF1 in neurofibromatosis type 1 (NF1) contributes to the development of a variety of tumors, including malignant peripheral nerve sheath tumors (MPNST) and benign neurofibromas. Of the different cell types found in neurofibromas, Schwann cells usually provide between 40 and 80%, and are thought to be critical for tumor growth. Here we describe the identification of growth factors that are upregulated in NF1−/− mouse Schwann cells and are potential regulators of angiogenesis and cell growth. Basic fibroblast growth factor (FGF-2), platelet-derived growth factor (PDGF) and midkine (MK) were found to be induced by loss of neurofibromin and MK was further characterized. MK was induced in human neurofibromas, schwannomas, and various nervous system tumors associated with NF1 or NF2; midkine showed an expression pattern overlapping but distinct from its homolog pleiotrophin (PTN). Immunohistochemistry revealed expression of MK in S-100 positive Schwann cells of dermal and plexiform neurofibromas, and in endothelial cells of tumor blood vessels, but not in normal blood vessels. Furthermore, MK demonstrated potent mitogenic activity for human systemic and brain endothelial cells in vitro and stimulated proliferation and soft agar colony formation of human MPNST derived S100 positive cells and fibroblastoid cells derived from an NF1 neurofibroma. The data support a possible central role for MK as a mediator of angiogenesis and neurofibroma growth in NF1.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Badache A and De Vries GH. . 1998 J. Cell. Physiol. 177: 334–342.

  • Bernards A. . 1995 Biochim. Biophys. Acta. 1242: 43–59.

  • Bloch B, Normand E, Kovesdi I and Bohlen P. . 1992 Brain Res. Dev. Brain Res. 70: 267–278.

  • Carmeliet P and Jain RK. . 2000 Nature 407: 249–257.

  • Chen JK, Yao LL and Jenq CB. . 1991 J. Neurosci. Res. 30: 321–327.

  • Costello P and DelMaestro R. . 1990 J. Neuro-Oncology 8: 231–243.

  • Choudhuri R, Hua-Tang Z, Donnini S, Ziche M and Bicknell R. . 1997 Cancer Res. 57: 1814–1819.

  • DeClue JE, Cohen BD and Lowy DR. . 1991 Proc. Natl. Acad. Sci. 88: 9914–9918.

  • DeClue JE, Papageorge AG, Fletcher A, Diehl SR, Ratner N, Vass WC and Lowy DR. . 1992 Cell 69: 265–273.

  • Dugoff L and Sujansky E. . 1996 Am. J. Med. Genet. 66: 7–10.

  • Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ and Moore MW. . 1996 Nature 380: 439–442.

  • Folkman J. . 1995 New Engl. J. Med. 333: 1757–1763.

  • Friesel RE and Maciag T. . 1995 FASEB J. 10: 919–925.

  • Garver Jr RI, Radford DM, Donis-Keller H, Wick MR and Milner PG. . 1994 Cancer 74: 1584–1590.

  • Gavrilovic J, Brennan A, Mirsky R and Jessen KR. . 1995 Eur. J. Neurosci. 7: 77–85.

  • Gutmann DH, Wood DL and Collins FS. . 1991 Proc. Natl. Acad. Sci. 88: 9658–9662.

  • Gutmann DH and Collins FS. . 1995 The Metabolic and Molecular Bases of Inherited Disease. Scriver et al., (eds), 7th edn. pp.667–696.

  • Hanahan D and Folkman J. . 1996 Cell 86: 353–364.

  • Ikematsu S, Yano A, Aridome K, Kikuchi M, Kumai H, Nagano H, Okamoto K, Oda M, Sakuma S, Aikou T, Muramatsu H, Kadomatsu K and Muramatsu T. . 2000 Br. J. Cancer 83: 701–706.

  • Iwasaki W, Nagata K, Hatanaka H, Inui T, Kimura T, Muramatsu T, Yoshida K, Tasumi M and Inagaki F. . 1997 EMBO J. 16: 6936–6946.

  • Kadomatsu K, Hagihara M, Akhter S, Fan QW, Muramatsu H and Muramatsu T. . 1997 Br. J. Cancer 75:: 354–359.

  • Kaname T, Kadomatsu K, Aridome K, Yamashita S, Sakamoto K, Ogawa M, Muramatsu T and Yamamura K. . 1996 Biochem. Biophys. Res. Commun. 219: 256–260.

  • Kaneda N, Talukder AH, Nishiyama H, Koizumi S and Muramatsu T. . 1996 J. Biochem. 119: 150–156.

  • Kato S, Ishihara K, Shinozawa T, Yamaguchi H, Asano Y, Saito M, Kato M, Terada T, Awaya A, Hirano A, Dickson DW, Yen SH and Ohama EJ. . 1999 Neuropathol. Exp. Neurol. 58: 430–441.

  • Kim HA, Rosenbaum T, Marchionni MA, Ratner N and DeClue JE. . 1995 Oncogene 11: 325–335.

  • Kim HA, Ling B and Ratner N. . 1997 Mol. Cell. Biol. 17: 862–872.

  • Kikuchi S, Muramatsu H, Muramatsu T and Kim SU. . 1993 Neurosci. Lett. 160: 9–12.

  • Kretschmer PJ, Fairhurst JL and Decker MM. . 1991 Growth Factors 5: 99–114.

  • Kurtz A, Zimmer A, Schnütgen F, Brüning G, Spener F and Müller T. . 1994 Development 120: 2637–2649.

  • Kurtz A, Schulte AM and Wellstein A. . 1995 Crit. Rev. Oncog. 6: 151–177.

  • Mashour GA, Wang HL, Cabal-Manzano R, Wellstein A, Martuza RL and Kurtz A. . 1999 J. Invest. Dermatol. 113: 398–402.

  • Matsumoto K, Wanaka A, Mori T, Taguchi A, Ishii N, Muramatsu H, Muramatsu T and Tohyama M. . 1994 Neurosci. Lett. 17: 216–220.

  • Milhiet PE, Vacherot F, Caruelle JP, Barritault D, Caruelle D and Courty J. . 1998 J. Endocrinol. 158: 389–399.

  • Mishima K, Asai A, Kadomatsu K, Ino Y, Nomura K, Narita Y, Muramatsu T and Kirino T. . 1997 Neurosci. Lett. 233: 29–32.

  • Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A and Brodeur GM. . 1995 Cancer Res. 55: 1792–1797.

  • Nakamoto M, Matsubara S, Miyauchi T, Obama H, Ozawa M and Muramatsu T. . 1992 J. Biochem. 112: 346–349.

  • O'Brien T, Cranston D, Fuggle S, Bicknell R and Harris AL. . 1996 Cancer Res. 56: 2515–2518.

  • Ohtani Y, Kijima H, Dowaki S, Kashiwagi H, Tobita K, Tsukui M, Tanaka Y, Tsuchida T, Tokunaga T, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Tajima T and Makuuchi H. . 1999 Int. J. Oncol. 15: 453–457.

  • Panoskaltsis-Mortari A and Bucy RP. . 1995 BioTechniques 18: 300–307.

  • Ratner N, Lieberman MA, Riccardi VM and Hong DM. . 1990 Ann. Neurol. 27: 298–303.

  • Salvesen HB and Akslen LA. . 1999 Int. J. Cancer 84: 538–543.

  • Schubert D. . 1992 J. Neurobiol. 23: 143–148.

  • Schulte A, Lai S, Kurtz A, Czubayko F, Riegel A and Wellstein A. . 1996 PNAS 93: 14759–14764.

  • Sheela S, Riccardi VM and Ratner N. . 1990 J. Cell. Biol. 111: 645–653.

  • Tsutsui J, Uehara K, Kadomatsu K, Matsubara S and Muramatsu T. . 1991 Biochem. Biophys. Res. Commun. 176: 792–797.

  • Tuszynsky GP and Nicosia RF. . 1996 Bioasssays 18: 71–76.

  • Vanderwinden JM, Mailleux P, Schiffmann SN and Vanderhaeghen JJ. . 1992 Anat. Embryol. (Berl) 186: 387–406.

  • Vogel KS, Brannan CI, Jenkins NA, Copeland NG and Parada LF. . 1995 Cell 82: 733–742.

  • Xu GF, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R and Tamanoi F. . 1990 Cell 63: 835–855.

  • Zhang N and Deuel TF. . 1999 Curr. Opin. Hematol. 6: 44–50.

  • Zoller ME, Rembeck B, Oden A, Samuelson M and Angervall L. . 1997 Cancer 79: 2125–2131.

Download references

Acknowledgements

We would like to thank Radhika Atit and Bo Ling of Nancy Ratner's laboratory for Schwann cell preparations, Dr Mia MacCollin of Mass General for generously sharing tumor tissues, and Dr Samuel Rabkin, Dr Anton Wellstein and Dr Anna Riegel of Georgetown for helpful contributions and support for this project. The work was supported by NIH grants R01-NS28840 to N Ratner and by R29-NS37895 to A Kurtz.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mashour, G., Ratner, N., Khan, G. et al. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells. Oncogene 20, 97–105 (2001). https://doi.org/10.1038/sj.onc.1204026

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204026

Keywords

This article is cited by

Search

Quick links